Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes

Circulation Research

Volumn 89, Issue 11, 2001, Pages 977-982

  Neri Serneri, Gian Gastone ^a   Boddi, Maria ^a   Modesti, Pietro Amedeo ^a   Cecioni, Ilaria ^a   Coppo, Mirella ^a   Padeletti, Luigi ^a   Michelucci, Antonio ^a   Colella, Andrea ^a   Galanti, Giorgio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hypertrophy, left ventricular; Insulin like growth factor I; Norepinephrine; Sympathetic nervous system exercise

Indexed keywords

ANGIOTENSIN; BIG ENDOTHELIN 1; ENDOTHELIN 1; NORADRENALIN; SOMATOMEDIN C;

ADULT; ARTICLE; ATHLETE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; ECHOCARDIOGRAPHY; HEART HYPERTROPHY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; HUMAN; HUMAN TISSUE; ISOTONIC EXERCISE; MALE; PRIORITY JOURNAL; SITTING; SYMPATHETIC TONE;

EID: 0035941414     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2301.100982     Document Type: Article

References (45)

1. Control of cardiac gene expression by mechanical stress
2. Basic determinants of myocardial hypertrophy: A review of molecular mechanisms
3. Cardiac growth factors in human hypertrophy: Relations with myocardial contractility and wall stress
4. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function
5. Sympathetic nervous activity during exercise
6. Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans
7. Norepinephrine spillover to plasma during steady-state supine bicycle exercise: Comparison of patients with congestive heart failure and normal subjects
8. Exercise training lowers resting renal but not cardiac sympathetic activity in humans
9. Norepinephrine spillover at rest and during submaximal exercise in young and old subjects
10. Silent ischemia in unstable angina is related to an altered cardiac norepinephrine handling
11. Structural features of the athlete heart as defined by echocardiography
12. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports
13. Athlete's heart: A meta-analysis of the echocardiographic experience
14. The athlete's heart: A meta-analysis of cardiac structure and function
15. Echocardiographic criteria of physiological left ventricular hypertrophy in combined strength- and endurance-trained athletes
16. Sports-specific adaptation of left ventricular muscle mass in athlete's heart, II: An echocardiographic study with 400-m runners and soccer players
17. Physiologic left ventricular cavity dilatation in elite athletes
18. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes
19. Left ventricular hypertrophy in athletes
20. Evidence for the existence of a functional cardiac renin-angiotensin system in humans
21. Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy
22. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes
23. Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading
24. Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure
25. Positive inotropic effect of insulin-like growth factor-I on normal and failing cardiac myocytes
26. Effects of constitutive overexpression of insulin-like growth factor-I on the mechanical characteristics and molecular properties of ventricular myocytes
27. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion
28. 2+ through a wortmannin-sensitive pathway: Studies in rat and ferret isolated muscles
29. The influence of endurance training on insulin-like growth factor-1 in older individuals
30. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes
31. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training
32. Clinical application of noradrenaline spillover methodology: Delineation of regional human sympathetic nervous responses
33. Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm
34. Early and late effects of exercise and athletic training on neural mechanisms controlling heart rate
35. Evidence for reduction of norepinephrine uptake sites in the failing human heart
36. α- and β-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells: Fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an α1-mediated response
37. Catecholamines modulate protein turnover in cultured, quiescent rabbit cardiac myocytes
38. Norepinephrine induces the raf-I kinase/mitogen-activated protein kinase cascade through both α1- and β-adrenoceptors
39. Sympathetic mechanisms regulating myocardial contractility in conscious animals
40. The electrocardiogram of athletes: Comparison with untrained subjects
41. Endurance exercise training augments diastolic filling at rest and during exercise in healthy young and older men
42. Comparison of 24-hour parasympathetic activity in endurance-trained and untrained young men
43. Effect of endurance exercise training on heart rate variability at rest in healthy young and older men
44. Norepinephrine response to exercise at the same relative intensity before and after endurance exercise training
45. Association of decreased myocardial β-receptors and chronotropic response to isoproterenol and exercise in pigs following chronic dynamic exercise